GSK-812 structure
|
Common Name | GSK-812 | ||
---|---|---|---|---|
CAS Number | 630407-66-8 | Molecular Weight | 471.99600 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C25H26ClNO4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of GSK-812GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina, shows has polypharmacology antagonizing multiple receptors, including D2 and D3 receptors, and 5-HT2A, 2C, and 5-HT6 receptors.. |
Name | 7-({4-[(4-Chlorobenzyl)oxy]phenyl}sulfonyl)-8-methoxy-3-methyl-2, 3,4,5-tetrahydro-1H-3-benzazepine |
---|---|
Synonym | More Synonyms |
Molecular Formula | C25H26ClNO4S |
---|---|
Molecular Weight | 471.99600 |
Exact Mass | 471.12700 |
PSA | 64.22000 |
LogP | 5.80950 |
~% GSK-812 CAS#:630407-66-8 |
Literature: GLAXO GROUP LIMITED Patent: WO2005/51916 A1, 2005 ; Location in patent: Page/Page column 7; 27 ; WO 2005/051916 A1 |
Precursor 2 | |
---|---|
DownStream 0 |
Abilitat-d8 |
Abilify-d8 |